Kaspersky Lab Appoints Maxim Mitrokhin as Managing Director for Asia Pacific
400 total views, 2 views today
Kaspersky Lab announces the appointment of Maxim Mitrokhin to the position of Managing Director of Kaspersky Lab Asia Pacific. Based in Singapore, Maxim will spearhead the company’s dynamic growth strategy in the region.
Having joined the company in 2008 as the Director of Operations in APAC, Maxim is now responsible for continuing Kaspersky Lab’s business growth in the region with a focus on reinforcing B2C market share, as well as driving channel engagements and development in the B2B sector.
“Kaspersky Lab’s APAC team is in top gear, as we take on the challenge of maintaining growth in the B2C market as well as expanding our enterprise security portfolio in the region. With Maxim at the helm, I am confident that his wealth of operational expertise and thorough understanding of the Kaspersky Lab proposition will push development forward in the SMB and enterprise markets and drive new initiatives and business growth,” said Garry Kondakov, Chief Business Officer at Kaspersky Lab.
With strong leadership skills and vast experience in the region, Maxim is ideally placed to take the Kaspersky Lab business to the next level.
Prior to joining Kaspersky Lab, Maxim held senior leadership roles at several high-growth companies including American Power Conversion and USP CompuLink.
“I am excited to lead and grow an already highly successful business in the Asia Pacific region. Our evolving portfolio of B2B products and business solutions combined with the strength of our channel network puts us in a great position to explore and exploit the full potential of the Asia Pacific market. I look forward to working with the team and our business partners to give the best to our users,” commented Maxim Mitrokhin, Managing Director at Kaspersky Lab Asia Pacific.
- Kaspersky Lab helps uncover vulnerabilities on gas stations by hackers - February 12, 2018
- 26-percent of Ransomware Attacks now target business - November 30, 2017
- The Battle is on to Fight Human Immunodeficiency Virus (HIV) - November 27, 2017